Researchers have discovered that digital breast tomosynthesis (DBT) can dramatically improve breast cancer detection in women with dense breast tissue when compared to traditional mammography methods, according to results published at the ARRS 2015 Annual Meeting in Toronto.

Scientific findings and the profession’s collective knowledge regarding cancer risks from radiation exposure resulting from CT scans are uncertain at best and are not enough to justify a policy requiring informed consent from patients and guardians, according to an editorial published in the May issue of Radiology.

Patients with early-stage Hodgkin’s lymphoma who receive negative findings on PET following three cycles of chemotherapy have a very good prognosis whether or not they received follow up radiotherapy, according to the U.K.-based RAPID trial.

More than 85 percent of surgeons—both breast specialists and general surgeons—continue to follow breast cancer screening recommendations more closely aligned with those of the American Cancer Society, the American College of Radiology (ACR) and the Society of Breast Imaging, rather than those issued by the U.S. Preventive Services Task Force (USPSTF), according to results presented April 21 at the ARRS 2015 Annual Meeting in Toronto.

ROCHESTER, N.Y., April 15 — Carestream earned the top rating in MD Buyline’s Market Intelligence Briefing™ (2015 Q1) for both portable and room-based DR systems. Carestream’s DRX-Revolution Mobile X-ray Systemand its DRX-Evolution and DRX-Ascend systems earned high marks from customers for system performance, reliability, installation and service repair quality. The DRX-Revolution was the highest rated portable system and Carestream’s DRX room-based platform tied for the highest rating in the DR room category. 

Siemens Healthcare has launched its new portable and compact ACUSON P500TM ultrasound system, FROSK edition, enabling rapid imaging even in difficult scanning conditions. The hand-held technology can be easily carried and positioned in a range of clinical environments and is ready to image in less than 30 seconds, making it ideal for emergency settings. The system introduces two new advanced technologies that ensure sharp ultrasound images, regardless of patient and probe motion.

When the U.S. Preventive Services Task Force (USPSTF) issued its 2009 recommendation for a limited mammography screening strategy, it was met with a flurry of controversy. The 2015 update is more of the same.

The FDA has approved the breast tomosynthesis add-on option for Siemens Healthcare’s MAMMOMAT Inspiration and MAMMOMAT Inspiration Prime Edition digital mammography systems.